Most European countries reported no changes in the rate of newly diagnosed cases of HIV or HIV prevalence in IDU in 2011.

This report presents the published evidence of sexual transmission of HIV among populations from countries with generalised HIV epidemics in the EU/EEA.

​This report highlights the benefits of a comprehensive approach to disease prevention, integrating HIV and STI control programming in Europe into broader public health strategies.

This report summarises the discussion and outcomes of a special satellite session at the 19th International AIDS Conference in Washington, DC, on 22 July 2012.

This literature review answers a series of questions on the prevalence of chronic HBV and HCV infection in the general EU population, the number of individuals with chronic HBV or HCV infection, and current national practices for screening for chronic HBV and HCV infection, all with the overarching goal of promoting national and European policies on the secondary prevention of these two diseases.

The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.

This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.